Anti-RIP3 抗体 [EPR24374-135]
Anti-RIP3 antibody [EPR24374-135]
- 20ul selling size
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal RIP3 antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications.
別名を表示する
RIP3, RIPK3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3
- WB
Supplier Data
Western blot - Anti-RIP3 antibody [EPR24374-135] (AB305054)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Negative control : MCF7, HepG2, A549 (PMID : 25675296) Lysates were freshly made and used immediately to minimize protein degradation. Exposure time : 26 seconds
All lanes:
Western blot - Anti-RIP3 antibody [EPR24374-135] (ab305054) at 1/1000 dilution
Lane 1:
U937 (human histiocytic lymphoma monocyte), whole cell lysate at 10 µg
Lane 2:
THP-1 (human monocytic leukemia monocyte), whole cell lysate at 10 µg
Lane 3:
MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 4:
HepG2 (human hepatocellar carcinoma epithelial cell), whole cell lysate at 10 µg
Lane 5:
A549 (human lung carcinoma epithelial cell), whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa
Observed band size: 56 kDa
false
Exposure time: 26s
- WB
Supplier Data
Western blot - Anti-RIP3 antibody [EPR24374-135] (AB305054)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Negative control : HeLa (PMID : 26269957, PMID : 28179994) Lysates were freshly made and used immediately to minimize protein degradation. Exposure time : 3 minutes
All lanes:
Western blot - Anti-RIP3 antibody [EPR24374-135] (ab305054) at 1/1000 dilution
Lane 1:
HT-29 (human colorectal adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 56 kDa
false
Exposure time: 3min
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-RIP3 antibody [EPR24374-135] - BSA and Azide free
Reactivity data
製品の詳細
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.
Pathways
RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (4)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:22592 PubMed40595878
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Tohoku journal of experimental medicine : PubMed39938906
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 28:529 PubMed39290957
2024
Applications
Unspecified application
Species
Unspecified reactive species
In vivo (Athens, Greece) 38:1162-1169 PubMed38688607
2024
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com